Evofem's SOLOSEC submitted for regulatory approval in the UAE
Marks first international filing for Evofem’s single-dose oral treatment
Marks first international filing for Evofem’s single-dose oral treatment
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Subscribe To Our Newsletter & Stay Updated